Moran Sean F. sold $121K of CRBP
Moran Sean F. (Chief Financial Officer) sold 12,000 shares of Corbus Pharmaceuticals Holdings, Inc. (CRBP) at $10.08 ($0.12M total) on 2026-08-07 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest disclosed fact is the CFO’s open-market sale of 12,000 shares at $10.0809 on 2026-08-07, with a 10b5-1 plan noted.
Market read
Traders may monitor insider activity for sentiment, but this filing alone does not provide a new fundamental catalyst.
What to watch
The article does not state whether other insiders sold/bought around the same period, nor does it provide context on total insider holdings changes beyond the post-transaction share count.
Background
The article is an SEC Form 4 insider transaction disclosure for Corbus Pharmaceuticals Holdings, Inc.
Ticker impact
Corbus Pharmaceuticals CFO Sean Moran sold 12,000 shares in an open-market transaction at $10.0809 on 2026-08-07 under a 10b5-1 plan.
Low likelihood of sustained price impact; any reaction is likely limited to short-term sentiment around insider selling.
The filing is a routine Form 4 insider transaction with a stated pre-arranged 10b5-1 plan, and the article provides no new operational, financial, or regulatory catalyst.
Market effects
Minimal; single-company insider sale does not materially reset sector expectations.
None indicated.
None indicated.
Counterpoint
Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may not signal bearish information and could be mechanically scheduled.
Key entities
- issuerCorbus Pharmaceuticals Holdings, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderSean F. Moran
Chief Financial Officer who sold shares under a 10b5-1 plan.